Skip to main navigation Skip to search Skip to main content

Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma

  • Philippe Armand
  • , Pier Luigi Zinzani
  • , Hun Ju Lee
  • , Nathalie A. Johnson
  • , Pauline Brice
  • , John Radford
  • , Vincent Ribrag
  • , Daniel Molin
  • , Theodoros P. Vassilakopoulos
  • , Akihiro Tomita
  • , Bastian von Tresckow
  • , Margaret A. Shipp
  • , Alex F. Herrera
  • , Jianxin Lin
  • , Eunhee Kim
  • , Samhita Chakraborty
  • , Patricia Marinello
  • , Craig H. Moskowitz

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience